Skip to content

Author

C. Yu

We have 5 of 281 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Aug 2026

Mid-Term Outcomes of Endovascular Aneurysm Repair With the INCRAFT Stent Graft System: Retrospective Combined Korean Multi-Center and Single-Center Registry Analysis.

In Korean patients with AAA, the INCRAFT stent-graft system demonstrated favorable mid-term outcomes, with low rates of aneurysm-related mortality, acceptable reintervention rates, and stable aneurysm sac behavior.

I. Jin, Young-Guk Ko, Seung-Jun Lee et al. · 0 citations
Open access Aug 2026

Efficacy and Safety of GNX80 in Patients with Peripheral Arterial Disease and Intermittent Claudication.

BACKGROUND AND OBJECTIVES Peripheral arterial disease (PAD) is associated with intermittent claudication (IC), leading to a lower quality of life. Although Ginkgo biloba extract (GbE) has been investigated for the treatment of IC, its clinical efficacy remains controversial. This study aimed to evaluate the efficacy an...

Onyou Kim, Seung-Hun Lee, J. Kim et al. · 0 citations
Open access Oct 2026

Cuffless 24-hour ambulatory blood pressure monitoring-guided antihypertensive titration in real-world clinical practice: a prospective non-randomized study

Background Twenty-four-hour ambulatory blood pressure monitoring (ABPM) is the reference standard for diagnosing hypertension and assessing treatment response, but routine use remains limited by conventional cuff-based devices. We compared 6-month ambulatory blood pressure (BP) between cuffless 24-hour ABPM-guided titr...

J. Cha, Mi-Na Kim, So Ree Kim et al. · 0 citations
Open access Aug 2026

Substantial Change Between Repeated Lipoprotein(a) Measurements Is Associated with Residual Cardiovascular Risk in a Real-World Multicenter Cohort

Intra-individual change in Lp(a) between two measurements is independently associated with cardiovascular outcomes but provides only modest incremental discrimination, which requires prospective validation before they can inform repeat-testing strategies.

Mi-Na Kim, Dongkuk Kim, S. Hong et al. · 0 citations
Open access Sep 2026

Efficacy and Safety of Fixed-Dose Combination Therapy with Cilostazol and Rosuvastatin in Patients with Symptomatic Lower Extremity Peripheral Artery Disease: A Multicenter Randomized Controlled Trial.

In patients with symptomatic PAD, the addition of cilostazol to rosuvastatin significantly improved patient-reported health status and provided additional favorable effects on atherogenic lipid profiles beyond rosuvastatin therapy alone.

A. Kemalasari, Dong-Woo Suh, I. Jin et al. · 1 citation

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.